Quetiapine XR in Schizophrenic Patients
This study has been terminated.
(Planned number of 30 subjects could not be recruited during recruitment phase.)
Sponsor:
Hannover Medical School
Collaborators:
Hannover Clinical Trial Center GmbH
AstraZeneca
Information provided by (Responsible Party):
Wolfgang Dillo, Hannover Medical School
ClinicalTrials.gov Identifier:
NCT01071135
First received: February 18, 2010
Last updated: November 10, 2011
Last verified: August 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | August 2010 |
| Primary Completion Date: | August 2010 (Final data collection date for primary outcome measure) |